Published in Antimicrob Agents Chemother on February 01, 1983
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Chlorpromazine as permeabilizer and reagent for detection of microbial peroxidase and peroxidaselike activities. Appl Environ Microbiol (1986) 0.87
Calmodulin activates prokaryotic adenylate cyclase. Proc Natl Acad Sci U S A (1980) 3.83
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization. J Bacteriol (1976) 2.95
Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science (1982) 1.30
Alteration of permeability of Lactobacillus plantarum caused by chlorpromazine. Nature (1961) 1.05
Decreased viscosity of human erythrocyte suspension induced by chlorpromazine and isoxsuprine. Biochem Pharmacol (1981) 1.02
Activation of prokaryotic adenylate cyclase by calmodulin. Ann N Y Acad Sci (1980) 0.98
Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine. Acta Microbiol Acad Sci Hung (1976) 0.95
Action of chlorpromazine on spore-forming Bacillus species. Can J Microbiol (1974) 0.85
Retardation of the emergence of isoniazid-resistant mycobacteria by phenothiazines and quinacrine. Proc Soc Exp Biol Med (1969) 0.82
Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother (1980) 23.54
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis (1984) 3.48
Risks to health care workers in developing countries. N Engl J Med (2001) 3.37
Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem (1983) 3.11
Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med (1988) 2.88
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69
Nucleotide sequence and characterization of a repetitive DNA element from the genome of Bordetella pertussis with characteristics of an insertion sequence. J Gen Microbiol (1988) 2.46
Occupational exposure to blood among medical students. N Engl J Med (1996) 2.31
Mechanism of lethal effect of human serum upon Leishmania donovani. J Immunol (1980) 2.08
Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis (1992) 1.99
Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol (1991) 1.90
Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun (1988) 1.89
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science (1994) 1.78
The immunobiology of leishmaniasis. Rev Infect Dis (1983) 1.76
Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem (1983) 1.74
N-Acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J Infect Dis (1985) 1.67
ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem (1984) 1.67
Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes. J Immunol (1981) 1.65
Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58
Experimental infection of mongrel dogs with Giardia lamblia cysts and cultured trophozoites. J Infect Dis (1982) 1.56
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Health advice for international travel. Ann Intern Med (1988) 1.51
Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest (1985) 1.49
Measles prophylaxis for international travel. Ann Intern Med (1989) 1.48
Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest (1993) 1.47
Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J Immunol (1986) 1.47
Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J Immunol (1989) 1.45
Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol (1987) 1.45
Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol (1991) 1.42
Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J Biol Chem (1983) 1.41
Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem (1989) 1.39
Species specificity of Bordetella adherence to human and animal ciliated respiratory epithelial cells. Infect Immun (1983) 1.36
Rhodopsin-enhanced GTPase activity of the inhibitory GTP-binding protein of adenylate cyclase. J Biol Chem (1984) 1.33
Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol (1987) 1.32
An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg (1995) 1.32
Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun (1987) 1.31
Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Science (1982) 1.30
Giardia lamblia infection of suckling mice. J Infect Dis (1983) 1.29
Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin Infect Dis (2000) 1.28
Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology (1997) 1.27
Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng (1986) 1.26
Characterization of a major peritrophic membrane protein, peritrophin-44, from the larvae of Lucilia cuprina. cDNA and deduced amino acid sequences. J Biol Chem (1996) 1.21
Pertussis toxin or phorbol 12-myristate 13-acetate can distinguish between epidermal growth factor- and angiotensin-stimulated signals in hepatocytes. Proc Natl Acad Sci U S A (1986) 1.20
Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect Immun (1999) 1.19
Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani. J Immunol (1982) 1.19
Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J Biol Chem (1994) 1.18
Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Ann Intern Med (1985) 1.18
Clinical, hemodynamic and sympathetic neural correlates of heart rate variability in congestive heart failure. Am J Cardiol (1992) 1.18
Antileishmanial activity of chlorpromazine. Antimicrob Agents Chemother (1984) 1.17
Niclosamide therapy for tapeworm infections. Ann Intern Med (1985) 1.17
Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J Clin Microbiol (1984) 1.15
Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett (1991) 1.15
Role of Ni in coupling angiotensin receptors to inhibition of adenylate cyclase in hepatocytes. J Biol Chem (1985) 1.13
NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease. Ann Intern Med (1984) 1.13
Vaccination against Boophilus microplus: localization of antigens on tick gut cells and their interaction with the host immune system. Exp Appl Acarol (1989) 1.12
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J Biol Chem (1995) 1.10
Interaction of Leishmania donovani promastigotes with human monocyte-derived macrophages: parasite entry, intracellular survival, and multiplication. Infect Immun (1981) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits? Infect Immun (1984) 1.10
Genetic studies of the molecular basis of whooping cough. Dev Biol Stand (1985) 1.09
Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun (2000) 1.09
Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol (2004) 1.07
Universal precautions: still missing the point on needlesticks. Infect Control Hosp Epidemiol (1991) 1.07
Bordetella extracytoplasmic adenylate cyclase: actions as a bacterial toxin. Dev Biol Stand (1985) 1.06
Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res (1978) 1.06
Circulating immune complexes and rheumatoid factors in visceral leishmaniasis. J Infect Dis (1983) 1.05
Immunization of cattle against Boophilus microplus using extracts derived from adult female ticks: effects of induced immunity on tick populations. Int J Parasitol (1986) 1.05
Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot. Mem Inst Oswaldo Cruz (1990) 1.05
ADP-ribosylation of transducin by pertussis toxin. J Biol Chem (1985) 1.05
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med (1985) 1.04
Amino acid-specific ADP-ribosylation. Sensitivity to hydroxylamine of [cysteine(ADP-ribose)]protein and [arginine(ADP-ribose)]protein linkages. J Biol Chem (1985) 1.03
Effects of guanyl nucleotides and rhodopsin on ADP-ribosylation of the inhibitory GTP-binding component of adenylate cyclase by pertussis toxin. J Biol Chem (1984) 1.03
Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum. J Immunol (1984) 1.03
Insect chitin synthase cDNA sequence, gene organization and expression. Eur J Biochem (2000) 1.02
Differential survival of Leishmania donovani amastigotes in human monocytes. J Immunol (1983) 1.02
Pertussis toxin treatment attenuates some effects of insulin in BC3H-1 murine myocytes. J Biol Chem (1988) 1.02
Recapping used needles: is it worse than the alternative? J Infect Dis (1990) 0.99
Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro. Antimicrob Agents Chemother (1992) 0.99